BIO2024: France BioLead and Business France hosted the panel "Innovations and Trends in Biomanufacturing"
France BioLead and Business France hosted the panel "Innovations and Trends in Biomanufacturing," a great opportunity to showcase the excellence of the French biomanufacturing sector on the global stage.
We were thrilled to welcome:
Lise ALTER, Managing Director of the Health Innovation Agency Agence de l'innovation en santé
Chloe Evans, Deputy Director General, Head of Market Research and International Relations at France Biotech (panel moderator)
Ninette van Lingen, Senior VP of Business Development at Just - Evotec Biologics
Laurent LAFFERRÈRE, PhD, eMBA Lafferrère, CEO of France BioLead
Key Highlights:
🌟 Lise Alter highlighted the robust government support for our sector, a strategic health priority under the france2030 plan, emphasizing the vibrant ecosystem in France from academic research to patient care.
🌟 Chloé Evans discussed the biotech companies perspective, stressing the main challenge: finding the right partner for their innovative biomanufacturing.
🌟 Ninette van Linguen shared technological insights, showcasing Evotec's successful France-US partnership with their Toulouse bioproduction site.
🌟 Laurent Lafferrère underscored France's growing prominence in Europe, now ranking 2nd in the development of hashtag#biomedicines, and emphasized the critical need for the right skills at the right time and place.
This event testifies to the dynamic and collaborative spirit driving our industry forward! 🌍
We were thrilled to welcome:
Lise ALTER, Managing Director of the Health Innovation Agency Agence de l'innovation en santé
Chloe Evans, Deputy Director General, Head of Market Research and International Relations at France Biotech (panel moderator)
Ninette van Lingen, Senior VP of Business Development at Just - Evotec Biologics
Laurent LAFFERRÈRE, PhD, eMBA Lafferrère, CEO of France BioLead
Key Highlights:
🌟 Lise Alter highlighted the robust government support for our sector, a strategic health priority under the france2030 plan, emphasizing the vibrant ecosystem in France from academic research to patient care.
🌟 Chloé Evans discussed the biotech companies perspective, stressing the main challenge: finding the right partner for their innovative biomanufacturing.
🌟 Ninette van Linguen shared technological insights, showcasing Evotec's successful France-US partnership with their Toulouse bioproduction site.
🌟 Laurent Lafferrère underscored France's growing prominence in Europe, now ranking 2nd in the development of hashtag#biomedicines, and emphasized the critical need for the right skills at the right time and place.
This event testifies to the dynamic and collaborative spirit driving our industry forward! 🌍